Pacira BioSciences, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pacira BioSciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2012 to Q2 2024.
  • Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $17.7M, a 46.4% increase year-over-year.
  • Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $37M.
  • Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $19.7M.
  • Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.61M, a 118% decline from 2021.
  • Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $14.4M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $37M $17.7M +$5.61M +46.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $31.3M $4.66M +$11.6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $19.7M $8.85M +$16.8M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $2.93M $5.74M +$2.98M +108% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$51K $12.1M +$9.96M +467% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$10M -$6.94M -$7.4M -1589% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2.61M -$7.97M -$6.9M -645% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.29M $2.76M -$3.81M -58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $8.1M $2.13M -$4.44M -67.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $12.5M $466K -$1.89M -80.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $14.4M -$1.07M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $6.57M +$131M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $6.57M +$6.61M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $2.36M +$1.96M +492% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 -$122M -$124M* -$124M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.97M -$42K +$1.56M +97.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $413K $398K +$145K +57.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $268K $1.35M +$1.31M +3445% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$1.04M $271K +$333K Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$1.37M -$1.6M -$1.64M -4680% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $264K $253K +$218K +623% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $46K $38K +$3K +8.57% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $43K -$62K -$107K -238% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $150K $35K +$5K +16.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $145K $35K +$5K +16.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $140K $35K +$56K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $84K $45K +$9K +25% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $75K $30K -$28K -48.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $103K $30K -$2K -6.25% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $105K -$21K +$87K +80.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $18K $36K -$245K -87.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $263K $58K +$19K +48.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $244K $32K -$20K -38.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $264K -$108K -$281K -162% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $545K $281K +$281K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $264K $39K +$39K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $225K $52K +$52K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $173K $173K +$173K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $0 $0 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $0 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $0 $0 +$442K Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 -$442K $0 Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $0 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$442K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.